Farming, Health and Environment Nepal Project (FHEN) Phase III

Duration: Jul 2021 - Dec 2024

Supporting Partner: Danish Civil Society Organizations DASAM/Dialogos

The third phase of the Farming, Health and Environment Nepal Project (FHEN) has been working in the Chitwan area since July 2021. The project aims to improve the health of farmers and consumers by promoting sustainable food production in Nepal. It focuses on reaching all municipalities in Chitwan District with an emphasis on unreached areas, shifting responsibilities to local governments and cooperative farmers’ associations. Field interventions will target the communities of 7 municipalities, with advocacy work aimed at the district, province, and federal levels of Nepal.

Ongoing Research

Research on “Pesticide Exposure during Pregnancy and Low Birth Weight in Young Women; a Hospital-Based Study in Chitwan District.”

The research project involves two data enumerators who will collect data over three months. The title of the research is “Pesticide Exposure during Pregnancy and Low Birth Weight in Young Women; a Hospital-Based Study in Chitwan District.” The overall objective of this research is to quantify the risk of delivering low birth weight babies in young women exposed to pesticides during pregnancy.

Global Antibiotic Resistance Partnership – Nepal (GARP-Nepal) Phase II

Duration: Feb 2023 - Jan 2024

Supporting Partner: The Center for Disease Dynamics, Economics and Policy

Objectives:

1. Initiate a conversation with experts in AMR and Immunization to assess the national perspectives on the connection between AMR mitigation and immunization strategies.
2. Create a working group to facilitate activities related to evidence generation and policy engagement.
3. Generate country-level estimates on the impact of vaccines in reducing infectious disease burden and AMR.
4. Develop national-level publications demonstrating the value of vaccines in mitigating AMR.
5. Convene experts and policymakers in a roundtable to present national-level evidence on the role of vaccines in mitigating AMR.